Oxidative Stress < Oxidopamine < Oxidoreductases

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 26.
[0-20] [0 - 20][0 - 26][20-25][20-40]

Ident.	Authors (with country if any)	Title
000A93 (2013)	Erwan Bezard [France] ; Elisabetta Tronci ; Elsa Y. Pioli ; Qin Li ; Gregory Porras ; Anders Björklund ; Manolo Carta	Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia.
000B78 (2013)	Maria Papathanou [Pays-Bas] ; Rika Van Der Laan ; Peter Jenner ; Sarah Rose ; Andrew C. Mccreary	Levodopa infusion does not decrease the onset of abnormal involuntary movements in parkinsonian rats.
000F37 (2012)	Cleide Lopes [Brésil] ; Andrea M. Esteves ; Roberto Frussa-Filho ; Sergio Tufik ; Marco Tulio De Mello	Evaluation of periodic limb movements in a putative animal model of restless leg syndrome.
001139 (2011)	Elisa Garbayo [Espagne] ; Eduardo Ansorena ; Jose Luis Lanciego ; María Jose Blanco-Prieto ; María S. Aymerich	Long-term neuroprotection and neurorestoration by glial cell-derived neurotrophic factor microspheres for the treatment of Parkinson's disease.
001224 (2011)	Davide Chiasserini [Italie] ; Alessandro Tozzi ; Antonio De Iure ; Michela Tantucci ; Federica Susta ; Pier Luigi Orvietani ; Keizo Koya ; Luciano Binaglia ; Paolo Calabresi	Mortalin inhibition in experimental Parkinson's disease.
001764 (2010)	Pauline Belujon [États-Unis] ; Daniel J. Lodge ; Anthony A. Grace	Aberrant striatal plasticity is specifically associated with dyskinesia following levodopa treatment.
001782 (2010)	Matteo Marti [Italie] ; Silvio Sarubbo ; Francesco Latini ; Michele Cavallo ; Roberto Eleopra ; Sara Biguzzi ; Christian Lettieri ; Carlo Conti ; Michele Simonato ; Silvia Zucchini ; Rocco Quatrale ; Mariachiara Sensi ; Sanzio Candeletti ; Patrizia Romualdi ; Michele Morari	Brain interstitial nociceptin/orphanin FQ levels are elevated in Parkinson's disease.
002944 (2007)	Martin Köllensperger [Autriche] ; Nadia Stefanova ; Markus Reindl ; Werner Poewe ; Gregor K. Wenning	Loss of dopaminergic responsiveness in a double lesion rat model of the Parkinson variant of multiple system atrophy.
002B63 (2006)	Gloria E. Meredith [États-Unis] ; Un Jung Kang	Behavioral models of Parkinson's disease in rodents: a new look at an old problem.
002D80 (2006)	Concepci Marin [Espagne] ; Esther Aguilar ; José A. Obeso	Coadministration of entacapone with levodopa attenuates the severity of dyskinesias in hemiparkinsonian rats.
002F35 (2005)	Pierre-Olivier Fernagut [États-Unis] ; Imad Ghorayeb ; Elsa Diguet ; François Tison	In vivo models of multiple system atrophy.
003421 (2004)	Gurutz Linazasoro [Espagne]	Recent failures of new potential symptomatic treatments for Parkinson's disease: causes and solutions.
003759 (2003)	Michael Orth [Royaume-Uni] ; Sarah J. Tabrizi	Models of Parkinson's disease.
003839 (2003)	Manuel Rodríguez Díaz [Espagne] ; Pedro Barroso-Chinea ; Abraham Acevedo ; Tomás González-Hernández	Effects of dopaminergic cell degeneration on electrophysiological characteristics and GAD65/GAD67 expression in the substantia nigra: different action on GABA cell subpopulations.
003860 (2003)	Peter Teismann [États-Unis] ; Kim Tieu ; Oren Cohen ; Dong-Kug Choi ; Du Chu Wu ; Daniel Marks ; Miquel Vila ; Vernice Jackson-Lewis ; Serge Przedborski	Pathogenic role of glial cells in Parkinson's disease.
003925 (2002)	Marie-Paule Muriel [France] ; Gaël Orieux ; Etienne C. Hirsch	Levodopa but not ropinirole induces an internalization of D1 dopamine receptors in parkinsonian rats.
003A67 (2002)	Joanne E. Nash [Royaume-Uni] ; Jonathan M. Brotchie	Characterisation of striatal NMDA receptors involved in the generation of parkinsonian symptoms: intrastriatal microinjection studies in the 6-OHDA-lesioned rat.
003C32 (2001)	O K Hassani [France] ; M. Mouroux ; G A Bohme ; J M Stutzmann ; J. Féger	Riluzole reduces hyperactivity of subthalamic neurons induced by unilateral 6-OHDA lesion in the rat brain.
003D52 (2001)	K P Datla [Royaume-Uni] ; S B Blunt ; D T Dexter	Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl(3) nigrostriatal lesions.
004046 (2000)	W G Ondo [États-Unis] ; Y. He ; S. Rajasekaran ; W D Le	Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome.
004379 (1998)	M. Gassen [Allemagne] ; A. Gross ; M B Youdim	Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i -k "Oxidopamine" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i  \
                -Sk "Oxidopamine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Oxidopamine
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024